Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now includes added institutional affiliations: Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, and Washington University School of Medicine. A new 'Helpful Links Provided by' header appears to indicate sources and related resources.SummaryDifference0.2%

- Check13 days agoChange DetectedTwo sponsor/institution credits were removed (Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine) and the 'Helpful Links Provided by' label was deleted; the revision tag was updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays a new revision tag: Revision: v3.6.4, replacing the previous Revision: v3.6.3. This is a minor version update and does not alter study content or functionality.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a new version of the page/system. This change does not modify the visible content or user-facing features.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now shows a new revision tag, v3.6.2, replacing the previous v3.6.0. This indicates a software update to the page’s template or underlying system rather than any change to visible content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe study page now indicates recruitment is closed for participants. Additionally, new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, along with a formatting adjustment for the Intervention/Treatment heading and a new revision note (Revision: v3.6.0) replacing the older one (Revision: v3.5.5).SummaryDifference0.4%

Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.